PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $330,000 | -19.1% | 140,847 | +1.5% | 0.00% | -50.0% |
| Q1 2018 | $408,000 | +55.7% | 138,708 | +44.8% | 0.00% | +100.0% |
| Q4 2017 | $262,000 | +2281.8% | 95,791 | +2094.0% | 0.00% | – |
| Q2 2017 | $11,000 | -52.2% | 4,366 | -57.2% | 0.00% | – |
| Q1 2017 | $23,000 | -96.9% | 10,206 | -97.1% | 0.00% | -100.0% |
| Q4 2016 | $734,000 | +14.9% | 346,013 | +317.7% | 0.00% | 0.0% |
| Q4 2014 | $639,000 | -62.3% | 82,829 | -63.5% | 0.00% | -62.5% |
| Q3 2014 | $1,693,000 | -27.9% | 226,704 | -6.5% | 0.01% | -27.3% |
| Q2 2014 | $2,347,000 | -52.7% | 242,470 | -59.4% | 0.01% | -52.2% |
| Q1 2014 | $4,965,000 | +19.2% | 597,489 | +21.1% | 0.02% | +21.1% |
| Q4 2013 | $4,164,000 | +15.3% | 493,357 | +8.9% | 0.02% | +5.6% |
| Q3 2013 | $3,611,000 | -0.0% | 453,074 | -3.2% | 0.02% | 0.0% |
| Q2 2013 | $3,612,000 | – | 467,898 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |